The condition encompasses a spectrum of pathophysiologic processes ranging from absolute insulin deficiency (Type 1) to progressive insulin secretory failure superimposed on insulin resistance (Type 2)
GLP-1 receptor agonists and menstrual cycle disruption in women with obesity
In addition, HO-1 and Nqo-1, two Nrf2-related genes, showed a downregulation after sitagliptin treatment (Figure 6A, C and D)
One of the most important antioxidants in the body, glutathione supports healthy detoxification
The formal name for GLP-1 medications is glucagon-like peptide-1 receptor agonists, and they mimic the action of a naturally occurring hormone (GLP-1, of course) in the body
In the beginning, conflicting results were obtained regarding the reduction in cardiovascular events in patients with HF